https://www.acumenresearchandconsulting.com/
Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Intravenous Immunoglobulin Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

Published : Jul 2023

Report ID: ARC3269

Pages : 250

Format : Intravenous Immunoglobulin Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Intravenous Immunoglobulin Market

1.1. Definition and Scope

1.1.1. Definition of Intravenous Immunoglobulin

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Intravenous Immunoglobulin Market

1.2. Summary

1.2.1. Executive Summary

1.2.2. Intravenous Immunoglobulin Market By Product

1.2.3. Intravenous Immunoglobulin Market By Application

1.2.4. Intravenous Immunoglobulin Market By Distribution Channel

1.2.5. Intravenous Immunoglobulin Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Intravenous Immunoglobulin Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Intravenous Immunoglobulin Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2022

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Intravenous Immunoglobulin Market By Product

4.1. Introduction

4.2. Intravenous Immunoglobulin Market Revenue By Product

4.2.1. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast, By Product, 2020-2032

4.2.2. IGG

4.2.2.1. IGG Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

4.2.3. IGA

4.2.3.1. IGA Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

4.2.4. IGM

4.2.4.1. IGM Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

4.2.5. IGD

4.2.5.1. IGD Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

4.2.6. IGE

4.2.6.1. IGE Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 5. Intravenous Immunoglobulin Market By Application

5.1. Introduction

5.2. Intravenous Immunoglobulin Market Revenue By Application

5.2.1. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast, By Application, 2020-2032

5.2.2. Immunodeficiency Diseases

5.2.2.1. Immunodeficiency Diseases Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Chronic Inflammatory Demyelinating Polyneuropathy

5.2.3.1. Chronic Inflammatory Demyelinating Polyneuropathy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Chronic Lymphocytic Leukemia & Myasthenia Gravis

5.2.4.1. Chronic Lymphocytic Leukemia & Myasthenia Gravis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.5. Hypogammaglobulinemia

5.2.5.1. Hypogammaglobulinemia Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.6. Congenital AIDS & Multifocal Motor Neuropathy

5.2.6.1. Congenital AIDS & Multifocal Motor Neuropathy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.7. Kawasaki Disease

5.2.7.1. Kawasaki Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.8. Guillain-Barre Syndrome

5.2.8.1. Guillain-Barre Syndrome Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.9. Immune thrombocytopenia (ITP)

5.2.9.1. Immune thrombocytopenia (ITP) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.10. Others

5.2.10.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Intravenous Immunoglobulin Market By Distribution Channel

6.1. Introduction

6.2. Intravenous Immunoglobulin Market Revenue By Distribution Channel

6.2.1. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032

6.2.2. Hospital Pharmacy

6.2.2.1. Hospital Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Specialty Pharmacy

6.2.3.1. Specialty Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Others

6.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. North America Intravenous Immunoglobulin Market By Country 

7.1. North America Intravenous Immunoglobulin Market Overview

7.2. U.S.

7.2.1. U.S. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

7.2.2. U.S. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

7.2.3. U.S. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

7.3. Canada

7.3.1. Canada Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

7.3.2. Canada Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

7.3.3. Canada Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

7.4. North America PEST Analysis

CHAPTER 8. Europe Intravenous Immunoglobulin Market By Country

8.1. Europe Intravenous Immunoglobulin Market Overview

8.2. U.K.

8.2.1. U.K. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

8.2.2. U.K. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

8.2.3. U.K. Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

8.3. Germany

8.3.1. Germany Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

8.3.2. Germany Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

8.3.3. Germany Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

8.4. France

8.4.1. France Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

8.4.2. France Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

8.4.3. France Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

8.5. Spain

8.5.1. Spain Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

8.5.2. Spain Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

8.5.3. Spain Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

8.6. Rest of Europe

8.6.1. Rest of Europe Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

8.6.2. Rest of Europe Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

8.6.3. Rest of Europe Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Intravenous Immunoglobulin Market By Country

9.1. Asia Pacific Intravenous Immunoglobulin Market Overview

9.2. China

9.2.1. China Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

9.2.2. China Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

9.2.3. China Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.3. Japan

9.3.1. Japan Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

9.3.2. Japan Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

9.3.3. Japan Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.4. India

9.4.1. India Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

9.4.2. India Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

9.4.3. India Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.5. Australia

9.5.1. Australia Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

9.5.2. Australia Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

9.5.3. Australia Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.6. South Korea

9.6.1. South Korea Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

9.6.2. South Korea Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

9.6.3. South Korea Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

9.7.2. Rest of Asia-Pacific Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

9.7.3. Rest of Asia-Pacific Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Intravenous Immunoglobulin Market By Country

10.1. Latin America Intravenous Immunoglobulin Market Overview

10.2. Brazil

10.2.1. Brazil Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

10.2.2. Brazil Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

10.2.3. Brazil Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.3. Mexico

10.3.1. Mexico Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

10.3.2. Mexico Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

10.3.3. Mexico Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.4. Rest of Latin America

10.4.1. Rest of Latin America Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

10.4.2. Rest of Latin America Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

10.4.3. Rest of Latin America Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Intravenous Immunoglobulin Market By Country 

11.1. Middle East & Africa Intravenous Immunoglobulin Market Overview

11.2. GCC

11.2.1. GCC Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

11.2.2. GCC Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

11.2.3. GCC Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.3. South Africa

11.3.1. South Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

11.3.2. South Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

11.3.3. South Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Product, 2020-2032

11.4.2. Rest of Middle East & Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Application, 2020-2032

11.4.3. Rest of Middle East & Africa Intravenous Immunoglobulin Market Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Intravenous Immunoglobulin Market

12.1. Intravenous Immunoglobulin Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Intravenous Immunoglobulin Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. Baxter International, Inc.

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (USD Billion), 2022

13.1.3.2. Baxter International, Inc. 2022 Intravenous Immunoglobulin Business Regional Distribution

13.1.4. Product /Service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. Bayer AG

13.3. Biotest AG (Tiancheng International Investment Limited)

13.4. CSL Limited (CSL Behring)

13.5. Grifols, S.A.

13.6. Kedrion S.p.A

13.7. LFB S.A.

13.8. Octapharma AG

13.9. Takeda Pharmaceutical Company Limited

Frequently Asked Questions

What was the size of the global intravenous immunoglobulin market in 2022?

The size of intravenous immunoglobulin market was USD 11.8 Billion in 2022.

What is the intravenous immunoglobulin market CAGR from 2023 to 2032?

The intravenous immunoglobulin market CAGR during the analysis period of 2023 to 2032 is 7.6%.

Which are the key players in the intravenous immunoglobulin market?

The key players operating in the global intravenous immunoglobulin market are including Baxter International, Inc., Bayer AG, Biotest AG (Tiancheng International Investment Limited), CSL Limited (CSL Behring), Grifols, S.A., Kedrion S.p.A, LFB S.A., Octapharma AG, and Takeda Pharmaceutical Company Limited.

Which region dominated the global intravenous immunoglobulin market share?

North America region held the dominating position in intravenous immunoglobulin industry during the analysis period of 2023 to 2032.

Which region registered fastest CAGR from 2023 to 2032?

Asia-Pacific region exhibited fastest growing CAGR for market of intravenous immunoglobulin during the analysis period of 2023 to 2032.

What are the current trends in the global intravenous immunoglobulin industry?

The current trends and dynamics in the intravenous immunoglobulin industry include increasing prevalence of immunodeficiency disorders and autoimmune diseases, growing geriatric population, and technological advancements in IVIG production and delivery methods

Which product held the maximum share in 2022?

The IGG product held the maximum share of the intravenous immunoglobulin industry.?

Select Licence Type

Single User

US$ 4500

Multi User

US$ 7000

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date